152 related articles for article (PubMed ID: 38009913)
1. Freedom isn't free: Assessing the risks and benefits of steroid-free immunosuppression regimens in pediatric liver transplantation in a real-world setting.
Peters AL; Perito ER
Liver Transpl; 2024 Mar; 30(3):242-243. PubMed ID: 38009913
[No Abstract] [Full Text] [Related]
2. Feasibility of steroid-free tacrolimus-basiliximab immunosuppression in pediatric liver transplantation and predictors for steroid requirement.
Trezeguet Renatti G; Riva N; Minetto J; Reijenstein H; Gole M; Meza V; Bosaleh A; Licciardone N; Aredes D; Lauferman L; Cervio G; Dip M; Schaiquevich P; Halac E; Imventarza O
Liver Transpl; 2024 Jan; 30(1):61-71. PubMed ID: 37439661
[TBL] [Abstract][Full Text] [Related]
3. Steroid-free immunosuppression in organ transplantation.
Luo G; Falta EM; Elster EA
Curr Diab Rep; 2005 Aug; 5(4):305-10. PubMed ID: 16033684
[TBL] [Abstract][Full Text] [Related]
4. Early steroids after pediatric liver transplantation protect against T-cell-mediated rejection: Results from the ChilSFree study.
Goldschmidt I; Chichelnitskiy E; Götz J; Rübsamen N; Karch A; Jäger V; Kelly D; Lloyd C; Debray D; Girard M; d'Antiga L; di Giorgio A; Hierro L; Pawlowska J; Klaudel-Dreszler M; McLin V; Korff S; Falk C; Baumann U
Liver Transpl; 2024 Mar; 30(3):288-301. PubMed ID: 37678230
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
Liu YY; Li CP; Huai MS; Fu XM; Cui Z; Fan LL; Zhang S; Liu Y; Ma J; Li G; Shen ZY
PLoS One; 2015; 10(3):e0120939. PubMed ID: 25816221
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression.
Spada M; Petz W; Bertani A; Riva S; Sonzogni A; Giovannelli M; Torri E; Torre G; Colledan M; Gridelli B
Am J Transplant; 2006 Aug; 6(8):1913-21. PubMed ID: 16771811
[TBL] [Abstract][Full Text] [Related]
7. Novel Immunosuppression in Solid Organ Transplantation.
Konda P; Golamari R; Eisen HJ
Handb Exp Pharmacol; 2022; 272():267-285. PubMed ID: 35318509
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppression Withdrawal After Liver Transplantation for Common Variable Immunodeficiency.
Detry O; Meurisse N; Jouret F; Bletard N; Delwaide J; Moutschen M
Liver Transpl; 2021 Feb; 27(3):456-458. PubMed ID: 32810897
[No Abstract] [Full Text] [Related]
9. Immunosuppression, Compliance, and Tolerance After Orthotopic Liver Transplantation: State of the Art.
Zorzetti N; Lauro A; Khouzam S; Marino IR
Exp Clin Transplant; 2022 Mar; 20(Suppl 1):3-9. PubMed ID: 35384800
[TBL] [Abstract][Full Text] [Related]
10. Minimization of steroids in liver transplantation.
Lerut J; Bonaccorsi-Riani E; Finet P; Gianello P
Transpl Int; 2009 Jan; 22(1):2-19. PubMed ID: 19121145
[TBL] [Abstract][Full Text] [Related]
11. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of steroid free immunosuppression with basiliximab induction in adult live donor liver transplantation (LDLT).
Kathirvel M; Mallick S; Sethi P; Thillai M; Durairaj MS; Nair K; Sunny A; Mathew JS; Varghese CT; Chandran B; Pillai Thankamony Amma BS; Menon RN; Balakrishnan D; Gopalakrishnan U; Surendran S
HPB (Oxford); 2021 May; 23(5):666-674. PubMed ID: 33032883
[TBL] [Abstract][Full Text] [Related]
13. Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?
Luan FL; Steffick DE; Ojo AO
Kidney Int; 2009 Oct; 76(8):825-30. PubMed ID: 19625995
[TBL] [Abstract][Full Text] [Related]
14. Towards tolerance in liver transplantation.
Toti L; Manzia TM; Sensi B; Blasi F; Baiocchi L; Lenci I; Angelico R; Tisone G
Best Pract Res Clin Gastroenterol; 2021; 54-55():101770. PubMed ID: 34874844
[TBL] [Abstract][Full Text] [Related]
15. Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?
Feng S
Curr Opin Organ Transplant; 2008 Oct; 13(5):506-12. PubMed ID: 19060534
[TBL] [Abstract][Full Text] [Related]
16. Steroid-free immunosuppression.
Ponticelli C
Transplant Proc; 2001; 33(7-8):3259-60. PubMed ID: 11750395
[No Abstract] [Full Text] [Related]
17. Current Use of Immunosuppression in Liver Transplantation.
Adjei M; Kim IK
Surg Clin North Am; 2024 Feb; 104(1):11-25. PubMed ID: 37953030
[TBL] [Abstract][Full Text] [Related]
18. "Not too much, not too little, just right"-Finding the Goldilocks point in pediatric immunosuppression minimization.
Diamond T; Rand EB
Liver Transpl; 2024 Jul; 30(7):676-677. PubMed ID: 38270574
[No Abstract] [Full Text] [Related]
19. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
[TBL] [Abstract][Full Text] [Related]
20. Induction and maintenance immunosuppression in pediatric kidney transplantation-Advances and controversies.
Balani SS; Jensen CJ; Kouri AM; Kizilbash SJ
Pediatr Transplant; 2021 Nov; 25(7):e14077. PubMed ID: 34216190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
